一名慢性粒细胞白血病患者中JAK2 V617F突变和Bcr-Abl易位的同时检测 - Suppr

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.

作者信息

de Conchon Monika Ribeiro Mello, Costa Juliana Lima, Novaes Mafalda Megumi Yoshinaga, Dorlhiac-Llacer Pedro Enrique, de Alencar Fischer Chamone Dalton, Bendit Israel

机构信息

Laboratorio de Biologia Tumoral da Disciplina de Hematologia da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil.

Department of the Tumor Biology Laboratory, Av. Dr. Eneias de Carvalho Aguiar, 155-1º andar,Cerqueira César, Sao Paulo, 05403-000, Brazil.

出版信息

Int J Hematol. 2008 Sep;88(2):243-245. doi: 10.1007/s12185-008-0131-2. Epub 2008 Jul 16.

DOI:10.1007/s12185-008-0131-2

PMID:18626727

Abstract

摘要

相似文献

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.一名慢性粒细胞白血病患者中JAK2 V617F突变和Bcr-Abl易位的同时检测

Int J Hematol. 2008 Sep;88(2):243-245. doi: 10.1007/s12185-008-0131-2. Epub 2008 Jul 16.

JAK2-V617F and BCR-ABL--double jeopardy?JAK2-V617F与BCR-ABL——双重风险？

Leuk Res. 2008 Oct;32(10):1489-90. doi: 10.1016/j.leukres.2008.03.011. Epub 2008 Apr 24.

Feasibility of Qualitative Testing of BCR-ABL and JAK2 V617F in Suspected Myeloproliperative Neoplasm (MPN) Using RT-PCR Reversed Dot Blot Hybridization (RT-PCR RDB).采用 RT-PCR 反向斑点杂交（RT-PCR RDB）对疑似骨髓增生性肿瘤（MPN）进行 BCR-ABL 和 JAK2 V617F 的定性检测的可行性。

Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):220-227. doi: 10.1016/j.clml.2019.01.005. Epub 2019 Jan 19.

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders.一名同时患有真性红细胞增多症和慢性髓性白血病的患者：两种疾病的动态变化。

Int J Hematol. 2010 Jan;91(1):136-9. doi: 10.1007/s12185-009-0471-6. Epub 2010 Jan 5.

Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.慢性髓性白血病患者同时存在 BCR-ABL 融合和 JAK2 V617F 突变。

Int J Hematol. 2014 Jan;99(1):87-90. doi: 10.1007/s12185-013-1480-z. Epub 2013 Nov 30.

Insights into JAK2-V617F mutation in CML.慢性粒细胞白血病中JAK2-V617F突变的见解。

Lancet Oncol. 2007 Oct;8(10):864-6. doi: 10.1016/S1470-2045(07)70295-4.

Concurrent JAK2-Positive Myeloproliferative Disorder and Chronic Myelogenous Leukemia: A Novel Entity? A Case Report With Review of the Literature.并发JAK2阳性骨髓增殖性疾病和慢性粒细胞白血病：一种新的实体？一例病例报告并文献复习

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832322. doi: 10.1177/2324709619832322.

Two cases of myeloproliferative neoplasm with a concurrent JAK2 (V617F) mutation and BCR/ABL translocation without chronic myelogenous leukemia phenotype acquisition during hydroxyurea treatment.两例骨髓增殖性肿瘤患者，伴有JAK2（V617F）突变和BCR/ABL易位，在羟基脲治疗期间未获得慢性粒细胞白血病表型。

Ann Lab Med. 2013 May;33(3):229-32. doi: 10.3343/alm.2013.33.3.229. Epub 2013 Apr 17.

Insights into JAK2-V617F mutation in CML.慢性粒细胞白血病中JAK2-V617F突变的研究进展

Lancet Oncol. 2007 Oct;8(10):863-4. doi: 10.1016/S1470-2045(07)70294-2.

Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients.JAK2 V617F 与 BCR-ABL 共存对费城阳性 CML 患者的临床和实验室意义。

Pak J Pharm Sci. 2021 Nov;34(6(Supplementary)):2289-2295.

引用本文的文献

Co-occurrence of mutation and translocation in chronic myeloproliferative neoplasms: a potentially confounding genetic combination.慢性骨髓增殖性肿瘤中突变与易位的同时出现：一种潜在的混淆性基因组合。

Front Oncol. 2024 Jan 12;13:1329298. doi: 10.3389/fonc.2023.1329298. eCollection 2023.

Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.成功治疗一名同时存在Janus激酶2（JAK2）R795S突变和断点簇区域-ABL1（BCR-ABL1）融合的慢性粒细胞白血病患者：病例报告及文献综述

Am J Case Rep. 2020 Oct 6;21:e925151. doi: 10.12659/AJCR.925151.

Emergence of Chronic Myeloid Leukemia in a -V617F Polycythemia Vera.JAK2 V617F 真性红细胞增多症患者中慢性髓性白血病的出现

J Hematol. 2020 Apr;9(1-2):23-29. doi: 10.14740/jh591. Epub 2020 Apr 23.

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832322. doi: 10.1177/2324709619832322.

Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.伴有 BCR-ABL1 易位和 JAK2 V617F 突变的骨髓增殖性肿瘤：来自骨髓病理学组的多机构研究。

Mod Pathol. 2018 May;31(5):690-704. doi: 10.1038/modpathol.2017.182. Epub 2018 Jan 12.

Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up.一名慢性髓性白血病患者在接受伊马替尼治疗并达到主要分子反应后长期随访期间，同时合并伴有JAK2 V617F突变的原发性血小板增多症。

Oncol Lett. 2016 Jul;12(1):485-487. doi: 10.3892/ol.2016.4631. Epub 2016 May 26.

Coexistence of JAK2V617F Mutation and BCR-ABL Translocation in a Pregnant Woman with Essential Thrombocythemia.一名患有原发性血小板增多症的孕妇中JAK2V617F突变与BCR-ABL易位并存。

Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):331-4. doi: 10.1007/s12288-014-0385-1. Epub 2014 Apr 11.

Chronic myeloid leukemia patient with co-occurrence of BCR-ABL junction and JAK2 V617F mutation.慢性髓性白血病患者同时存在 BCR-ABL 融合和 JAK2 V617F 突变。

Int J Hematol. 2014 Jan;99(1):87-90. doi: 10.1007/s12185-013-1480-z. Epub 2013 Nov 30.

Ann Lab Med. 2013 May;33(3):229-32. doi: 10.3343/alm.2013.33.3.229. Epub 2013 Apr 17.

JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?JAK2 与骨髓增殖性肿瘤的基因组不稳定性：先有鸡还是先有蛋？

Am J Hematol. 2012 Nov;87(11):1028-36. doi: 10.1002/ajh.23243. Epub 2012 May 28.

本文引用的文献

Insights into JAK2-V617F mutation in CML.慢性粒细胞白血病中JAK2-V617F突变的见解。

Lancet Oncol. 2007 Oct;8(10):864-6. doi: 10.1016/S1470-2045(07)70295-4.

Insights into JAK2-V617F mutation in CML.慢性粒细胞白血病中JAK2-V617F突变的研究进展

Lancet Oncol. 2007 Oct;8(10):863-4. doi: 10.1016/S1470-2045(07)70294-2.

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.一名费城染色体阳性慢性髓性白血病患者的JAK2-V617F突变

Lancet Oncol. 2007 Jul;8(7):658-60. doi: 10.1016/S1470-2045(07)70206-1.

Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis.骨髓纤维化中定向髓系祖细胞内JAK2（V617F）突变与BCR-ABL易位并存

Leukemia. 2007 Aug;21(8):1824-6. doi: 10.1038/sj.leu.2404730. Epub 2007 May 3.

Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation.在伊马替尼治疗慢性骨髓增殖性疾病期间发生的骨髓纤维化，该疾病同时存在BCR-ABL易位和JAK2V617F突变。

Blood. 2007 May 1;109(9):4106-7. doi: 10.1182/blood-2006-12-061135.

The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders.V617F JAK2突变在癌症及除经典骨髓增殖性疾病外的髓系恶性肿瘤中并不常见。

Blood. 2005 Oct 15;106(8):2920-1. doi: 10.1182/blood-2005-05-2087.

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.人类骨髓增殖性疾病中酪氨酸激酶JAK2的获得性突变。

Lancet. 2005;365(9464):1054-61. doi: 10.1016/S0140-6736(05)71142-9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献